Berenberg Bank Reiterates “Buy” Rating for Advanced Medical Solutions Group (LON:AMS)

Berenberg Bank reiterated their buy rating on shares of Advanced Medical Solutions Group (LON:AMS) in a research report released on Tuesday morning, Marketbeat reports. Berenberg Bank currently has a GBX 300 ($3.66) price target on the stock.

Advanced Medical Solutions Group Stock Down 0.5 %

AMS stock opened at GBX 217 ($2.65) on Tuesday. Advanced Medical Solutions Group has a 1-year low of GBX 176.60 ($2.16) and a 1-year high of GBX 275.83 ($3.37). The business’s 50 day simple moving average is GBX 204 and its 200 day simple moving average is GBX 220.12. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The firm has a market capitalization of £465.57 million, a PE ratio of 4,340.00, a PEG ratio of 5.00 and a beta of 0.74.

Insider Buying and Selling at Advanced Medical Solutions Group

In other news, insider Eddie Johnson sold 34,235 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of GBX 218 ($2.66), for a total transaction of £74,632.30 ($91,115.00). Corporate insiders own 3.12% of the company’s stock.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.